Inolife Technologies Announces Moving Forward Strategies Are to Develop a Formidable Operation as a Life Sciences Company in

Inolife Technologies Announces Moving Forward Strategies Are to Develop a
Formidable Operation as a Life Sciences Company in Multiple Market Verticals

Company's Trading Symbol Changed to INOLD, Which Should be for About 20
Calendar Days, Then it Will Revert Back to INOL

RALEIGH, N.C., Jan. 25, 2013 (GLOBE NEWSWIRE) -- Inolife Technologies, Inc.
("Inolife") (OTCQB:INOLD), an emerging life sciences company announces its
strategies to effectively move forward with its plans to develop a formidable
operation in multiple market verticals.

Historically, Inolife's mission has been to identify and develop meaningful
healthcare products for consumers exclusively. Today, Inolife is embarking on
strategies to deploy several products to the market that will service a wide
variety of consumer and commercial/industrial needs."We are immediately
creating three distinct operating units within Inolife," states Gary Berthold,
President & CEO of Inolife.Berthold goes on to say that, "In today's market,
we are interested in having the Company specialize in bringing to market a
great variety of consumer- and commercial-centric products, which are natural
and health-safe technologies that excel in performance, and cater to the
market's desires of improving health-friendly and environmental stewardship."

The Company is immediately creating three operating units to address these
following distinct touch points:(1) Health & Wellness – This strategic unit
will house products to include nutracueticals and natural & organic food
products.Several products for the growing population of pets in today's
society will also be housed within this unit. (2) Anti-Aging – The historic
core product of Inolife, a patented high-performance technology, will be in
this unit, along with additional products oriented toward the growing consumer
needs and desires to reduce the effects of aging.The Company will expand its
offering of nutracueticals, natural topical ointments and salves to cater to
the increasing aging population. (3) Life Sciences – This business unit will
focus on the development and introduction of natural, organic, dynamic
chemistry and nanotechnology formulations.Key products within this unit will
include proprietary bio-remediation product line, as well as several highly
advanced eco-safe industrial and consumer chemical formulations that cater to
the ever-present "green initiatives" in society today. In doing so, the
Company will integrate via acquisition and licensing agreements a wide array
of products to service these consumer and commercial interests.

Berthold also said, "I am delighted and excited to bring a highly defined
strategy to fruition within Inolife. The Company will begin announcing
licensing agreements, acquisitions, private label agreements, and product
introductions imminently."

About Inolife Technologies, Inc.

Inolife Technologies' mission is to aggressively identify, manufacture and
market innovative and affordable healthcare products and services directly to
the marketplace. InoLife Technologies, Inc. markets the commercial use of
proprietary Intellectual Property by manufacturing, brand marketing and
selling an integrated program of age reversing creams and lotions.

"Safe Harbor Statement"

InoLife Technologies, Inc. believes it is well prepared to succeed in both its
geographic and strategic focus areas based on the new ideas and extensive
experience of its management team. One of our most important responsibilities
is to communicate with shareholders in an open and direct manner. Comments are
based on current management expectations, and are considered "forward-looking
statements," generally preceded by words such as "plans," "expects,"
"believes," "anticipates," or "intends." We cannot promise future returns. Our
statements reflect our best judgment at the time they are issued, and we
disclaim any obligation to update or alter forward-looking statements as the
result of new information or future events. InoLife Technologies, Inc. urges
investors to review the risks and uncertainties contained within its filings
with the Securities and Exchange Commission. For further company information,
please visit

CONTACT: Inolife Technologies, Inc
         Investor Relations:
         William A. Young Sr. Ph: 623-238-5245
Press spacebar to pause and continue. Press esc to stop.